1Hosenpud JD, Bennett LE, Keck BM, et al. The registry of the international society for heart and lung transplantation: fifteenth official report-1998. J Heart Lung Transplant, 1998,17:656-668.
2Bittner HB, Kendall SWH, Chen EP, et al. The effects of brain death on cardiopulmonary hemodynamics and pulmonary blood flow characteristics. Chest,1995,108:1358-1363.
3Pison U, Seeger W, Buchhorn R, et al. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis, 1989,140:1033-1039.
4Anderson BO, Moore EE, Moore FA, et al. Hypovolemic shock promotes neutrophil sequestration in lung by a xanthine oxidase-related mechanism. J Appl Physiol, 1991,71:1862-1865.
5Mason J, Williams MC. Type II alveolar cell: defender of the alveolus. Am Rev Respir Dis, 1977,116:81-91.
6Crestani B, Cornillet P, Dehoux M, et al. Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo: regulation by alveolar macrophage secretory products. J Clin Invest,1994,94:731-740.
7Standiford TJ, Kunkel SL, Basha MA, et al. Intereukin-8 gene expression by a pulmonary epitheial cell line: a model for cytokine networks in the lung. J Clin Invest,1990,86:1945-1953.
8Al-Mehdi AB, Zhao G, Dodia C, et al. Endothelial NADPH oxidase as the source of oxidants with lung ischemia or high K+. Circ Res, 1998,83:730-737.
9Steimle CN, Guynn TP, Morganroth ML, et al. Neutrophils are not necessary for ischemia-reperfusion lung injury. Ann Thorac Surg, 1992,53:64-73.
10Wang LS, Yoshikawa K, Miyoshi S, et al. The effect of ischemic time and temperature on lung preservation in a simple ex vivo rabbit model used for functional assessment. J Thorac Cardiovasc Surg, 1989,98:333-342.
